The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
EIP Pharma announced the initiation of a new Phase 2 proof-of-concept study evaluating neflamapimod as a treatment for the cognitive dysfunction ...
read more
Geneos announced the first cancer patient was dosed using the company's GT-EPIC Neoantigen-Targeting Personalized Vaccine Technology.
read more
American Regent has announced the introduction of Selenious Acid Injection, USP.
read more
GSK will begin shipping its quadrivalent influenza vaccines to US healthcare providers and pharmacies for the 2019-20 flu season, immediately ...
read more
Eton announced the FDA provided Eton’s partner with a CRL relating to the application for EM-100, an OTC eye drop for the treatment of ocular itching ...
read more
Pharmazz has received permission to initiate a study to assess efficacy of PMZ-1620 along with standard treatment in patients of acute ischemic stroke...
read more
The FDA has approved multiple applications for first generics of Lyrica (pregabalin) for the management of multiple medical issues.
read more
After review of the requested submission, FDA notified the Company of additional nonclinical data requirements and placed the IND on a partial ...
read more
Arena announced the first subject has been dosed in trial evaluating olorinab for the treatment of visceral pain associated with gastrointestinal ...
read more
Harrow Health has filed a Form 8-K with the Securities and Exchange Commission containing a corporate presentation for its subsidiary, Mayfield ...
read more
GEMoaB GmbH announced the dosing of the first patient in a Phase I open-label, dose escalation study of GEM3PSCA, an Affinity-Tailored Adapter for T-...
read more
The FDA has issued the draft guidance, General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products.
read more
Wednesday, August 07, 2019
Leap announced DKN-01, in combination with Keytruda, demonstrated higher survival and objective response outcomes in advanced gastroesophageal ...
read more
Sesen Bio reported updated endpoint data from the Company’s trial further supporting the strong benefit-risk profile of Vicinium for the potential ...
read more
Immunic announced enrollment of the first patient in a clinical trial of IMU-838 for the treatment of patients with primary sclerosing cholangitis.
read more